- Report
- October 2024
- 180 Pages
Global
From €2139EUR$2,400USD£1,850GBP
- Report
- September 2024
- 180 Pages
Global
From €2942EUR$3,300USD£2,544GBP
- Report
- May 2024
- 100 Pages
Global
From €2139EUR$2,400USD£1,850GBP
- Report
- November 2023
- 1800 Pages
Global
From €4546EUR$5,100USD£3,931GBP
- Report
- November 2023
- 88 Pages
Global
From €1783EUR$2,000USD£1,542GBP
- Report
- May 2023
- 1500 Pages
China
From €4546EUR$5,100USD£3,931GBP
- Report
- April 2023
- 75 Pages
Global
From €1605EUR$1,800USD£1,387GBP
- Report
- February 2023
- 129 Pages
Global
From €2674EUR$3,000USD£2,312GBP
- Report
- September 2022
- 300 Pages
China
From €2674EUR$3,000USD£2,312GBP
- Report
- May 2022
- 510 Pages
Global
From €2674EUR$3,000USD£2,312GBP
- Drug Pipelines
- March 2022
- 900 Pages
Global
From €8023EUR$9,000USD£6,937GBP
- Report
- February 2022
- 360 Pages
United States
From €3209EUR$3,600USD£2,775GBP
- Report
- November 2021
- 222 Pages
Global
From €2674EUR$3,000USD£2,312GBP
- Report
- October 2021
- 180 Pages
Global
From €2139EUR$2,400USD£1,850GBP
- Report
- April 2021
- 150 Pages
Global
From €2139EUR$2,400USD£1,850GBP
- Report
- July 2020
- 1200 Pages
Japan
From €2674EUR$3,000USD£2,312GBP
- Report
- March 2018
- 255 Pages
Global
From €2318EUR$2,600USD£2,004GBP
- Clinical Trials
- February 2018
- 225 Pages
Global
From €2139EUR$2,400USD£1,850GBP
- Report
- January 2025
- 140 Pages
Global
From €2139EUR$2,400USD£1,850GBP
- Report
- March 2025
- 320 Pages
Global
From €2674EUR$3,000USD£2,312GBP

Preclinical Development is a critical step in the drug discovery process. It involves the testing of potential drugs on animals and in vitro systems to assess their safety and efficacy. This stage of development is used to identify potential risks and to determine the optimal dose and route of administration. Preclinical Development also includes the development of manufacturing processes and the evaluation of drug stability.
The Preclinical Development market is highly competitive and consists of a variety of companies, ranging from large pharmaceutical companies to small biotechnology firms. These companies provide services such as drug discovery, preclinical testing, and manufacturing process development. They also offer consulting services to help clients navigate the drug development process.
Some of the major players in the Preclinical Development market include Charles River Laboratories, WuXi AppTec, Covance, Parexel, and Syngene. Show Less Read more